Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on managing complexity and improving lives. It provides medicines to address unmet patient needs, stemming from nearly 150 years of using its unique strengths, experience and expertise to help improve people's lives. Mallinckrodt's growing portfolio of specialty pharmaceuticals and global medical imaging products has expanded to help treat a wide variety of health conditions, from pain to central nervous system disorders to autoimmune and rare diseases.